Publication | Closed Access

High-dose melphalan and autologous bone marrow support for treatment of ovarian carcinoma with positive second-look operation

Hematological MalignancyMedicineMalignant Blood DisorderGynecologyOvarian CarcinomaCancer TreatmentOncologyRadiation OncologyGynecology OncologyHigh-dose MelphalanOvarian CancerPositive Second-look Operation